Zhang et al. conducted a non-randomized clinical trial involving SLE patients with infection who were already taking high doses of prednisone (30mg/day median) and demonstrated a significant increase in Treg cell and CD8+ T cell populations in patients who were given low-dose IL2 therapy [17]. Here, IL2 is linked to systemic lupus erythematosus.